| ULTRACEF ORAL SUSPANSIYON ICIN KURU TOZ 250 mg/5 ml 100 ml şişe | |||||||||
| Tarih |
Etiket Fiyat |
Kamu Fiyat |
KKİ Oranı |
Depocu Fiyat |
İmalatçı Fiyat |
Eşdeğer Kod |
Referans Grup |
Değişim Türü |
|
| 19.04.2024 | 166,49 | 118,25 | 109,67 | E385B | SGK | ||||
| 25.12.2023 | 166,49 | 119,87 | 28,00% | 118,25 | 109,67 | E385B | TİTCK | ||
| 27.10.2023 | 133,03 | 109,08 | 18,00% | 94,48 | 87,74 | E385B | SGK | ||
| 11.08.2023 | 133,03 | 109,08 | 18,00% | 94,48 | 87,74 | E385B | SGK | ||
| 24.07.2023 | 133,03 | 109,08 | 18,00% | 94,48 | 87,74 | E385B | TİTCK | ||
| 10.07.2023 | 102,14 | 83,75 | 18,00% | 72,54 | 67,24 | E385B | TİTCK | ||
| 15.12.2022 | 100,28 | 82,23 | 18,00% | 72,54 | 67,24 | E385B | TİTCK | ||
| 28.07.2022 | 73,54 | 66,19 | 10,00% | 53,20 | 49,17 | E385B | SGK | ||
| 09.07.2022 | 73,54 | 53,20 | 49,17 | E385B | TİTCK | ||||
| 14.04.2022 | 57,49 | 42,58 | 39,34 | E385B | SGK | ||||
| 19.02.2022 | 57,49 | 51,74 | 10,00% | 42,58 | 39,34 | E385B | TİTCK | ||
| 09.09.2021 | 41,87 | 41,87 | 0,00% | 31,02 | 28,63 | E385B | SGK | ||
| 27.05.2021 | 41,87 | 31,02 | 28,63 | E385B | SGK | ||||
| 20.02.2021 | 41,87 | 41,87 | 0,00% | 31,02 | 28,63 | E385B | TİTCK | ||
| 18.06.2020 | 34,92 | 34,92 | 0,00% | 25,86 | 23,86 | E385B | SGK | ||
| 19.02.2020 | 34,92 | 34,92 | 0,00% | 25,86 | 23,86 | E385B | TİTCK | ||
| 19.02.2019 | 31,17 | 31,17 | 0,00% | 23,09 | 21,29 | E385B | TİTCK | ||
| 31.05.2018 | 24,70 | 24,70 | 0,00% | 18,29 | 16,85 | E385B | TİTCK | ||
| 19.02.2018 | 24,70 | 24,70 | 0,00% | 18,29 | 16,85 | E385B | TİTCK | ||
| 20.02.2017 | 21,50 | 21,50 | 0,00% | 15,93 | 14,66 | E385B | TİTCK | ||
| 23.02.2016 | 19,45 | 19,45 | 0,00% | 14,41 | 13,25 | E385B | SGK | ||
| 22.02.2016 | 19,45 | 19,45 | 0,00% | 14,41 | 13,25 | E385B | TİTCK | ||
| 04.09.2015 | 19,11 | 19,11 | 0,00% | 14,16 | 13,02 | E385B | TİTCK | ||
| 01.06.2015 | 18,40 | 18,40 | 0,00% | 13,63 | 12,53 | E385B | TİTCK | ||
| 11.04.2015 | 18,03 | 18,03 | 0,00% | 13,36 | 12,28 | E385B | SGK | ||
| 10.04.2015 | 18,03 | 13,36 | 12,28 | TİTCK | |||||